Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study
Explore this paper's citation graph
Summary
The current prospective, multicenter study sought to identify single nucleotide polymorphisms of voltage‐gated sodium channels (SCNAs) genes that might confer susceptibility to an increased incidence and severity of oxaliplatin‐induced peripheral neuropathy (OXAIPN) in patients treated with either leucovorin, 5‐fluorouracil, and oxali Platin.
- Type
- article
- Published
- 2013-10-01
- Cited by
- 97
- References
- 31
- Access
- Open access
- OpenAlex
- https://openalex.org/W23821303
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8375192
Keywords
Gerontology, Depression (economics), Medicine, Elderly people
References
- Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
- Clinical pattern and associations of oxaliplatin acute neurotoxicity
- Integrin beta‐3 L33P: a new insight into the pathogenesis of chronic oxaliplatin‐induced peripheral neuropathy?
- The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
- Sickle Cell Disease: Genetics, Cellular and Molecular Mechanisms, and Therapies
- Novel Insights into the Pathomechanisms of Skeletal Muscle Channelopathies
- Oxaliplatin‐induced neurotoxicity and the development of neuropathy
- From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.
- Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
- Polymorphic markers associated with severe oxaliplatin‐induced, chronic peripheral neuropathy in colon cancer patients
- A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen
- A review on oxaliplatin-induced peripheral nerve damage.
- Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.
- Genome-wide association study of PR interval
- Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
- Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current
- Pain perception is altered by a nucleotide polymorphism in SCN9A
- Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
- XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
Cited by
- Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
- Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol.
- Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
- Genetic determinants of chronic oxaliplatin‐induced peripheral neurotoxicity: a genome‐wide study replication and meta‐analysis
- Investigating the genetics and pharmacogenetics of bowel cancer
- Painful neuropathies: the emerging role of sodium channelopathies
- Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective
- Ion channel expression as promising cancer biomarker.
- Platinum-induced neurotoxicity and preventive strategies: past, present, and future.
- Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
- Mitotoxicity in distal symmetrical sensory peripheral neuropathies
- Chemotherapy-induced peripheral neuropathy in the adult
- Peripheral Neuropathy Due to Vitamin Deficiency, Toxins, and Medications
- Reliability and accuracy of quantitative sensory testing for oxaliplatin‐induced neurotoxicity
- Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.
- Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry
- Long‐term course of oxaliplatin‐induced polyneuropathy: a prospective 2‐year follow‐up study
- Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity
- Informative gene network for chemotherapy-induced peripheral neuropathy
- A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
Related papers
No related papers recorded.